Anti-CRACC antibodies are used in antigen-specific immunodetection in biological samples. The target CRACC is a known alias name of the protein SLAM family member 7, encoded by the SLAMF7 gene in humans. This 335-amino acid residue protein is reported to be a self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. It is localized to the membrane of the cell and features glycosylated post-translational modifications. In terms of tissue expression, it is reported to be expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. Indicated applications for CRACC antibodies listed below include ELISA, Flow Cytometry, Western Blot, and Immunohistochemistry.